Evidence map›Paper›PMID 38954014›Full record

ReviewApplied microbiology and biotechnology2024

Catabolism of 2-keto-3-deoxy-galactonate and the production of its enantiomers.

Eun Ju Yun, Sun-Hee Lee, Subin Kim, Hae Seul Ryu, Kyoung Heon Kim

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eun Ju YunDivision of Biotechnology, Jeonbuk National University, Iksan, 54596, Republic of Korea.
Sun-Hee LeeDepartment of Biotechnology, Graduate School, Korea University, Seoul, 02841, Republic of Korea.
Subin KimDivision of Biotechnology, Jeonbuk National University, Iksan, 54596, Republic of Korea.
Hae Seul RyuDivision of Biotechnology, Jeonbuk National University, Iksan, 54596, Republic of Korea.
Kyoung Heon KimDepartment of Biotechnology, Graduate School, Korea University, Seoul, 02841, Republic of Korea. khekim@korea.ac.kr.ORCID http://orcid.org/0000-0003-4600-8668

Funding

Ministry of Agriculture, Food, and Rural Affairs 32136-05-1-SB010National Research Foundation of Korea RS-2023-00247769
6 · The paper itself

Abstract

2-Keto-3-deoxy-galactonate (KDGal) serves as a pivotal metabolic intermediate within both the fungal D-galacturonate pathway, which is integral to pectin catabolism, and the bacterial DeLey-Doudoroff pathway for D-galactose catabolism. The presence of KDGal enantiomers, L-KDGal and D-KDGal, varies across these pathways. Fungal pathways generate L-KDGal through the reduction and dehydration of D-galacturonate, whereas bacterial pathways produce D-KDGal through the oxidation and dehydration of D-galactose. Two distinct catabolic routes further metabolize KDGal: a nonphosphorolytic pathway that employs aldolase and a phosphorolytic pathway involving kinase and aldolase. Recent findings have revealed that L-KDGal, identified in the bacterial catabolism of 3,6-anhydro-L-galactose, a major component of red seaweeds, is also catabolized by Escherichia coli, which is traditionally known to be catabolized by specific fungal species, such as Trichoderma reesei. Furthermore, the potential industrial applications of KDGal and its derivatives, such as pyruvate and D- and L-glyceraldehyde, are underscored by their significant biological functions. This review comprehensively outlines the catabolism of L-KDGal and D-KDGal across different biological systems, highlights stereospecific methods for discriminating between enantiomers, and explores industrial application prospects for producing KDGal enantiomers. KEY POINTS: • KDGal is a metabolic intermediate in fungal and bacterial pathways • Stereospecific enzymes can be used to identify the enantiomeric nature of KDGal • KDGal can be used to induce pectin catabolism or produce functional materials.

Indexed as

Metabolic Networks and PathwaysSugar AcidsBacteriaEscherichia coliFungiGalactoseStereoisomerismGalactoseSugar Acids2-Keto-3-deoxy-galactonateCatabolismEnantiomerGlyceraldehydePyruvateStereospecificity

Identifiers

PMID38954014
PMCPMC11219438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.